Legal Opinion
Sec. & Exch. Comm'n v. Johnston
District Court, District of Columbia
Decided April 19, 2018No. Civil Action No. 16–10607–NMGPublishedCited by 1 opinion
1Opinion of the Court
Nathaniel M. Gorton, United States District Judge
This case arises out of the development of a cancer drug by AVEO Pharmaceuticals, Inc. ("AVEO"). The Securities and Exchange Commission ("the SEC") alleges that AVEO, its chief executive officer Tuan Ha-Ngoc ("Ha-Ngoc"), chief financial officer David Johnston ("Johnston" or "defendant") and its chief medical officer William Slichenmyer ("Slichenmyer") made materially misleading statements to investors about communications with the Food and Drug Administration ("the FDA") during their bid for approval of their flagship drug candidate, tivozanib…
2Cases cited20 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Ernst & Ernst v. HochfelderSupreme Court of the United States · 1976
- Basic Inc. v. LevinsonSupreme Court of the United States · 1988
15 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- O'Connell v. Town of TewksburyDistrict Court, D. Massachusetts · 2018